Variations in cardiovascular risk factors in people with and without migration background in Germany - Results from the STAAB cohort study.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 07 2019
Historique:
received: 27 06 2018
revised: 02 10 2018
accepted: 29 10 2018
pubmed: 14 11 2018
medline: 13 2 2020
entrez: 14 11 2018
Statut: ppublish

Résumé

About 20% of the German population have a migration background which might influence prevalence of preventable cardiovascular risk factors (CVRF). We report data of the prospective Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression (STAAB) cohort study investigating a representative sample of inhabitants of the City of Würzburg, Germany, aged 30 to 79 years. Individuals without migration background were defined as follows: German as native language, no other native language, and/or born in Germany. All other participants were defined as individuals with migration background. Of 2473 subjects (51% female, mean age 54 ± 12 years), 291 (12%) reported a migration background: n = 107 (37%) from a country within the EU, n = 117 (40%) from Russia, and n = 67 (23%) from other countries. Prevalence of hypertension, atherosclerotic disease, and diabetes mellitus was similar in individuals with and without migration background. By contrast, prevalence of obesity and metabolic syndrome was significantly higher in individuals with migration background, with the least favourable profile apparent in individuals from Russia (individuals without vs. with migration background: obesity 19 vs. 24%, p < 0.05; odds ratio: EU: 1.6, Russia: 2.2*, other countries: 0.6; metabolic syndrome 18 vs. 21%, p < 0.05; odds ratio: EU: 1.2, Russia: 1.7*, other countries: 1.5; *p < 0.05). Individuals with migration background in Germany might exhibit a higher CVRF burden due to a higher prevalence of obesity and metabolic syndrome. Strategies for primary prevention of heart failure may benefit from deliberately considering the migration background.

Sections du résumé

BACKGROUND
About 20% of the German population have a migration background which might influence prevalence of preventable cardiovascular risk factors (CVRF).
METHODS
We report data of the prospective Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression (STAAB) cohort study investigating a representative sample of inhabitants of the City of Würzburg, Germany, aged 30 to 79 years. Individuals without migration background were defined as follows: German as native language, no other native language, and/or born in Germany. All other participants were defined as individuals with migration background.
RESULTS
Of 2473 subjects (51% female, mean age 54 ± 12 years), 291 (12%) reported a migration background: n = 107 (37%) from a country within the EU, n = 117 (40%) from Russia, and n = 67 (23%) from other countries. Prevalence of hypertension, atherosclerotic disease, and diabetes mellitus was similar in individuals with and without migration background. By contrast, prevalence of obesity and metabolic syndrome was significantly higher in individuals with migration background, with the least favourable profile apparent in individuals from Russia (individuals without vs. with migration background: obesity 19 vs. 24%, p < 0.05; odds ratio: EU: 1.6, Russia: 2.2*, other countries: 0.6; metabolic syndrome 18 vs. 21%, p < 0.05; odds ratio: EU: 1.2, Russia: 1.7*, other countries: 1.5; *p < 0.05).
CONCLUSION
Individuals with migration background in Germany might exhibit a higher CVRF burden due to a higher prevalence of obesity and metabolic syndrome. Strategies for primary prevention of heart failure may benefit from deliberately considering the migration background.

Identifiants

pubmed: 30420145
pii: S0167-5273(18)34130-5
doi: 10.1016/j.ijcard.2018.10.098
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

186-189

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Caroline Morbach (C)

Comprehensive Heart Failure Center and Dept. of Medicine I, University Hospital and University of Würzburg, Germany.

Götz Gelbrich (G)

Institute of Clinical Epidemiology and Biometry and Comprehensive Heart Failure Center, University of Würzburg, Germany.

Theresa Tiffe (T)

Institute of Clinical Epidemiology and Biometry and Comprehensive Heart Failure Center, University of Würzburg, Germany.

Felizitas Eichner (F)

Institute of Clinical Epidemiology and Biometry and Comprehensive Heart Failure Center, University of Würzburg, Germany.

Martin Wagner (M)

Institute of Clinical Epidemiology and Biometry and Comprehensive Heart Failure Center, University of Würzburg, Germany.

Peter U Heuschmann (PU)

Institute of Clinical Epidemiology and Biometry, Comprehensive Heart Failure Center, and Clinical Trial Center, University of Würzburg, Germany.

Stefan Störk (S)

Comprehensive Heart Failure Center and Dept. of Medicine I, University Hospital and University of Würzburg, Germany. Electronic address: Stoerk_S@ukw.de.

S Frantz (S)

Dept. of Medicine I, Div. of Cardiology, University Hospital Würzburg, Germany.

C Maack (C)

Comprehensive Heart Failure Center, University Hospital and University of Würzburg, Germany.

G Ertl (G)

University Hospital Würzburg, Germany.

M Fassnacht (M)

Dept. of Medicine I, Div. of Endocrinology, University Hospital Würzburg, Germany.

C Wanner (C)

Dept. of Medicine I, University Hospital Würzburg, Germany.

R Leyh (R)

Dept. of Cardiovascular Surgery, University Hospital Würzburg, Germany.

J Volkmann (J)

Dept. of Neurology, University Hospital Würzburg, Germany.

J Deckert (J)

Dept. of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital Würzburg, Germany.

H Faller (H)

Dept. of Medical Psychology, University of Würzburg, Germany.

R Jahns (R)

Interdisciplinary Bank of Biomaterials and Data Würzburg, University Hospital Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH